[ad_1]
About 30 countries closed their borders to people traveling from Great Britain or South Africa, where new variants of the coronavirus were discovered, to stop any spread.
An NHS pharmacy technician holds a vial while simulating the preparation of the Pfizer-BioNTech coronavirus vaccine during a staff training session prior to the vaccine launch on December 8, 2020. Image: AFP.
BERLIN – The BioNTech co-founder said Tuesday that his coronavirus vaccine was “very likely” to work against the mutated variant detected in Britain, but could also tailor the vaccine if necessary within six weeks.
“Scientifically, it is very likely that the immune response of this vaccine can also cope with the new variant of the virus,” said Ugur Sahin.
ALSO READ: Here’s the difference between a variant and a strain
But if necessary, “in principle, the beauty of messaging technology is that we can start directly designing a vaccine that fully mimics this new mutation; we might be able to technically provide a new vaccine in six weeks.”
About 30 countries closed their borders to people traveling from Great Britain or South Africa, where new variants of the coronavirus were discovered, to stop any spread.
Download the EWN app on your iOS or Android device.
[ad_2]
